参考文献/References:
[1] Seker Yilmaz B, Baruteau J, Arslan N, et al. Three-CountrySnapshot of Ornithine Transcarbamylase Deficiency. Life (Basel),2022, 12 (11): 1721.
[2] Merritt JL, Brody LL, Pino G, et al. Newborn screening forproximal urea cycle disorders: Current evidence supportingrecommendations for newborn screening. Mol Genet Metab,2018,124(2):109-113.
[3] Couchet M, Breuillard C, Corne C, et al. OrnithineTranscarbamylase - From Structure to Metabolism: An Update.Front Physio, 2021, 12:748249.
[4] Lopes FF, Sitta A, de Moura Coelho D, et al. Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy. Int J Dev Neurosci, 2022, 82 (8):772-788.
[5] Gropman AL, Prust M, Breeden A, et al. Urea cycle defects and hyperammonemia: effects on functional imaging. Metab BrainDis, 2013, 28 (2): 269-275.
[6] Burrage LC, Thistlethwaite L, Stroup BM, et al. Untargetedmetabolomic profiling reveals multiple pathway perturbationsand new clinical biomarkers in urea cycle disorders. Genet Med,2019, 21 (9):1977-1986.
[7] Krijt Jakub , Sokolová Jitka , Je?ina Pavel , et al. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LCMS/MS assay for non-invasive diagnosis of ornithinecarbamoyltransferase deficiency. Clin Chem Lab Med, 2017, 55(8):1168-1177.
[8] Sen K, Castillo Pinto C, Gropman AL. Expanding Role of Proton Magnetic Resonance Spectroscopy: Timely Diagnosis andTreatment Initiation in Partial Ornithine TranscarbamylaseDeficiency. J Pediatr Genet, 2021, 10 (1):77-80.
[9] Committee of Clinical Biochemical Genetics, Branch of Medical Genetic Physician, Chinese Medical Doctor Association, et al.Guidelines for diagnosis, treatment and management of ureacycle disorders in China. Zhonghua Er Ke Za Zhi, 2022, 60 (11):1118-1126.
[10] 中国妇幼保健协会儿童疾病和保健分会遗传代谢学组 .鸟氨酸氨甲酰转移酶缺乏症诊治专家共识 . 浙江大学学报(医学版),2020, 49(5):539-547.
[11] Singh RH, Rhead WJ, Smith W, et al. Nutritional management ofurea cycle disorders. Crit Care Clin, 2005, 21 (4 Suppl): S27-S35.
[12] H?berle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis, 2019, 42 (6): 1192-1230.
[13] 左俊焘, 李嘉琪, 徐 瑶, 等 . 重症病人肠内营养中断现状及其对热卡达标的影响研究 . 肠外与肠内营养,2023,30(3):166-170.
[14] Andrews A, Roberts S, Botto LD. Benefits of tailored disease management in improving tremor, white matter hyperintensities, and liver enzymes in a child with heterozygous X-linked ornithine transcarbamylase deficiency. Mol Genet Metab Rep,2022, 33 (Suppl 1): 100891.
[15] Timmer C, Davids M, Nieuwdorp M, et al. Differences in faecal microbiome composition between adult patients with UCD and PKU and healthy control subjects. Mol Genet Metab Rep, 2021,29:100794
[16] 顾学范, 韩连书, 余永国 . 中国新生儿遗传代谢病筛查现状及展望 . 罕见病研究,2022,1(1):13-19.